文献速递心脑血管急症重症综合管理与镇静镇痛

院内心脏骤停后的温度控制:来自Discover院内心脏骤停队列的结果

Temperature Control After In-Hospital Cardiac Arrest: Outcomes From the Discover In-Hospital Cardiac Arrest Cohort.
PubMed 文献 · Crit Care Med · 2026-03-20
一句话结论昏迷的院内心脏骤停幸存者中仅44.4%有温度控制策略记录,有策略者发热更少但生存与神经功能结局无差异。

该前瞻性观察性队列研究纳入2023年10月至2024年6月来自24个医院系统、46家收治医院的成人院内心脏骤停后初始复苏成功且仍昏迷、符合温度控制条件的患者。1006例入组患者中615例(61.1%)符合条件,仅273例(44.4%)在骤停后24小时内有温度控制策略记录。有策略记录与接受温度控制治疗几率更高(aOR 21.3,95%CI 12.3-36.7)及复苏后24小时内发热几率更低(aOR 0.63,95%CI 0.43-0.92)相关,但与出院生存、良好功能结局及良好神经功能结局均无统计学显著关联。各医院系统温度控制策略比例从0%到100%不等,提示实践差异巨大。

要点

  • 昏迷的院内心脏骤停幸存者中仅44.4%(273/615)在骤停后24小时内有温度控制策略记录,超过半数未记录。
  • 有温度控制策略记录者接受温度控制治疗的调整比值比为21.3(95%CI 12.3-36.7),复苏后24小时内发热(≥38°C)的调整比值比为0.63(95%CI 0.43-0.92)。
  • 有策略与无策略相比,出院生存率32.6% vs 28.1%(aOR 1.19,95%CI 0.79-1.80),无统计学显著差异。
  • 良好功能结局(mRS≤3)有策略9.9% vs 无策略10.5%(aOR 1.14,95%CI 0.53-2.42),良好神经功能结局(CPC≤2)12.8% vs 12.3%(aOR 1.15,95%CI 0.63-2.12),均无统计学显著差异。
  • 各医院系统温度控制策略比例从0%到100%不等,提示院内心脏骤停后温度控制实践存在显著机构间差异。

适用人群与场景

  • 成人院内心脏骤停患者,初始复苏后存活且仍处于昏迷状态、符合温度控制条件者。
  • 研究场景为24个医院系统、46家收治医院的多中心国际队列。

诊断标准与关键阈值

  • 发热定义为体温≥38°C。
  • 良好功能结局定义为改良Rankin量表(mRS)≤3。
  • 良好神经功能结局定义为脑功能分级(CPC)≤2。
  • 主要暴露为骤停后24小时内温度控制策略的记录。

研究设计与关键结果

  • 研究类型为前瞻性观察性队列研究,数据收集时间为2023年10月至2024年6月,来自24个医院系统、46家收治医院的多中心国际队列。
  • 1006例入组患者中615例(61.1%)仍昏迷且符合温度控制条件,其中273例(44.4%)有温度控制策略记录。
  • 有策略记录者接受温度控制治疗的调整比值比为21.3(95%CI 12.3-36.7,p<0.01),复苏后24小时内发热的调整比值比为0.63(95%CI 0.43-0.92,p=0.02)。
  • 有策略与无策略相比,出院生存率32.6% vs 28.1%(aOR 1.19,95%CI 0.79-1.80,p=0.42),无统计学显著差异。
  • 良好功能结局有策略9.9% vs 无策略10.5%(aOR 1.14,95%CI 0.53-2.42,p=0.74),无统计学显著差异。
  • 良好神经功能结局有策略12.8% vs 无策略12.3%(aOR 1.15,95%CI 0.63-2.12,p=0.65),无统计学显著差异。
  • 各医院系统温度控制策略比例从0%到100%不等。

证据类型、等级与局限

  • 证据类型为前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于院内心脏骤停后初始复苏成功且仍昏迷的患者,本研究显示仅44.4%有温度控制策略记录,记录策略与发热减少及接受温度控制治疗几率增高相关,但与生存、功能及神经功能结局无统计学显著关联。
  • 各医院系统温度控制策略比例从0%到100%不等,提示机构间实践差异显著。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: A temperature control strategy is strongly recommended for comatose in-hospital cardiac arrest (IHCA) survivors. We aimed to investigate variation in adherence to this recommendation and associations with outcomes, which have not been comprehensively assessed for IHCA.

DESIGN: Prospective observational cohort study with data collected from October 2023 to June 2024.

SETTING: Multicenter, international (24 hospital systems, 46 enrolling hospitals).

PATIENTS: Adults who suffered IHCA, survived initial resuscitation, and remained comatose and eligible for temperature control.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The main exposure was documentation of a temperature control strategy in the first 24 hours after arrest. Outcomes were survival to hospital discharge (primary), use of temperature control therapy, fever (temperature ≥ 38°C), favorable functional outcome (modified Rankin Scale ≤ 3), and favorable neurologic outcome (Cerebral Performance Category score ≤ 2). Among 1006 enrolled patients, 615 (61.1%) remained comatose and were eligible for temperature control; of those, 273 (44.4%) had a documented temperature control strategy. A documented strategy was associated with higher adjusted odds of receiving a temperature control therapy (adjusted odds ratio [aOR], 21.3; 95% CI, 12.3-36.7; p < 0.01), and lower adjusted odds of fever in the first 24 hours after resuscitation (aOR, 0.63; 95% CI, 0.43-0.92; p = 0.02). Having a strategy, compared with not, had no statistically significant association with survival (32.6% vs. 28.1%; aOR, 1.19; 95% CI, 0.79-1.80; p = 0.42), favorable functional outcome (9.9% vs. 10.5%; aOR, 1.14; 95% CI, 0.53-2.42; p = 0.74), or favorable neurologic outcome (12.8% vs. 12.3%; aOR, 1.15; 95% CI, 0.63-2.12; p = 0.65). Hospital system specific proportions of temperature control strategy ranged from 0% to 100%.

CONCLUSIONS: Among comatose IHCA survivors, more than half received no documented temperature control strategy. Those with a strategy were less likely to have a fever and more likely to receive temperature control directed therapy, but showed no difference in survival, functional, or neurologic outcomes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Andrea L, Berg KM, Johnson NJ, et al. Temperature Control After In-Hospital Cardiac Arrest: Outcomes From the Discover In-Hospital Cardiac Arrest Cohort. Crit Care Med. 2026. PMID: 41860326. doi:10.1097/CCM.0000000000007121

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。